Skip to main content

Table 4 Multivariate Cox regression analyses on recurrence-free survival of urothelial carcinoma, intravesical recurrence and upper tract recurrence in patients between three groups, history of urothelial cancers (UTUC or bladder) vs. history of non-urothelial cancers vs. no history of any cancer

From: Impact of previous malignancy at diagnosis on oncological outcomes of upper tract urothelial carcinoma

 

Urothelial carcinoma

Intravesical recurrence

Upper tract recurrence

 

HR(95% CI)

P value

HR(95% CI)

P value

HR(95% CI)

P value

Smoke

 

0.058

 

0.695

 

0.312

No

Reference

 

Reference

 

Reference

 

Yes

1.416

(0.988–2.029)

 

0.993

(0.657–1.323)

 

1.298

(0.783–2.154)

 

Gender

 

0.102

 

0.540

 

0.084

Female

Reference

 

Reference

 

Reference

 

Male

0.754

(0.537–1.058)

 

1.121

(0.778–1.616)

 

0.660

(0.412–1.057)

 

Previous malignancy

 

0.151

 

0.013*

 

0.013*

Non-HPM

Reference

 

Reference

 

Reference

 

Uro-HPM

1.408

(0.985–2.014)

0.061

0.981

(0.641–1.502)

0.931

1.938

(1.214–3.095)

0.006**

Non-uro-HPM

1.229

(0.794–1.901)

0.355

1.810

(1.206–2.719)

0.004**

0.874

(0.430–1.777)

0.710

pT Stage

 

0.012*

 

0.760

 

0.139

Ta/Tis/T1

Reference

 

Reference

 

Reference

 

T2-4

1.598

(1.111-2.300)

 

1.059

(0.732–1.534)

 

0.668

(0.391–1.140)

 

Tumor Grade

 

0.419

 

0.537

 

0.013*

G1-2

Reference

 

Reference

 

Reference

 

G3

0.867

(0.613–1.226)

 

0.891

(0.617–1.286)

 

1.916

(1.145–3.204)

 
  1. CI = confidence interval; HR = hazard ratio; PM = History of previous malignancy
  2. *p < 0.05; **p < 0.01; and ***p < 0.001